Sichenzia Ross Ference Kesner LLP Represents Cannabinoid Based Therapeutics Company in $12.3 Million Private Placement Led by Tuatara Capital Fund I, Ltd.
Press Release – New York, NY – March 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented a cannabinoid based life sciences corporation whose technology is designed to synthetically produce medically beneficial cannabinoids without utilizing the actual cannabis plant for the customized treatment of disease. Last year, Tuatara and its affiliates invested $7.0 million in a Series A Financing for the company. The Sichenzia Ross Ference Kesner LLP team was led by partners Darrin M. Ocasio and Arthur Marcus and associate Ashley Jaber. Sichenzia Ross Ference Kesner LLP is a leader in the representation of cannabis related companies.
- Sichenzia Ross Ference LLP任命Andrew Bernstein为合伙人，领导白领刑事辩护业务 - May 4, 2020
- Sichenzia Ross Ference LLP代表Aegis Capital进行Avinger，Inc.的315万美元公开发行 - April 30, 2020
- 60天并不断增长：“最佳监管”即将到来。准备好独立经纪交易商了吗？他们需要知道和做什么 - April 29, 2020